New Imaging Technology Could Speed Up Cancer Diagnosis
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
A $4 million financing round will support development of a liquid specimen biorepository and expand biopsy catchment pilot programs at medical institutions across the US.
Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
The MMR IHC Panel pharmDx helps identify patients eligible for immunotherapy treatment with Bristol Myers Squibb's Opdivo alone or in combination with Yervoy.
Evident has launched the IXplore IX85 SpinXL and SpinSR, two advanced spinning disk confocal microscopes that enhance live-cell imaging.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.